Peptides Explained

John Garrett

Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more. Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they’re popular, what the research shows, and the real risks and side effects — all in plain language. No bro science. No hype. Just clear, foundational education. For informational purposes only. Not medical advice. For Research Peptides; Offlinepeptides.com/ref/johngarrett/ https://www.skool.com/peptides-explained-15

  1. Can Peptides Help Menopause? The Truth About Libido, Weight Gain & Aging

    1 jam lalu

    Can Peptides Help Menopause? The Truth About Libido, Weight Gain & Aging

    In this special episode of Peptides Explained, we're focusing on a topic that affects millions of women but often isn't discussed openly enough: menopause, hormonal signaling, libido, body composition, and the emerging role of peptides. Why does weight gain seem different during menopause? What causes the sudden changes in energy, sleep, skin, hair, and sexual desire? And where do peptides like Kisspeptin, PT-141 (Bremelanotide), Tesamorelin, GHK-Cu, BPC-157, and GLP-1 medications fit into the conversation? Join host John Garrett, RN, as he breaks down the science behind female hormone signaling in clear, understandable language. We'll explore the biology of menopause, the neurochemistry of desire, the "collagen cliff," metabolic changes, and the latest research on peptides being studied for women's health and aging. This episode covers:• Menopause and metabolic changes• GLP-1 medications and weight management• Kisspeptin and reproductive hormone signaling• PT-141 and female sexual desire• Tesamorelin and growth hormone pathways• GHK-Cu and collagen production• BPC-157 and recovery science• Oxytocin and emotional connection• What is evidence-based vs. what remains experimental Whether you're navigating perimenopause, menopause, or simply interested in understanding how peptide science intersects with women's health, this episode delivers a balanced, evidence-based look at one of the most important conversations in modern medicine. Learn more:www.peptide-solutions.info Podcast website:www.peptidesexplained.info Support the podcast and learn more about peptide research:offlinepeptides.com/ref/JohnGarrett Affiliate Disclosure: Peptides Explained is an affiliate partner with Offline Peptides. If you use my affiliate link, I may earn a commission at no additional cost to you. Follow Peptides Explained:• Instagram: @PeptidesExplained• Facebook: Peptides Explained• LinkedIn: Peptides Explained• Patreon: Peptides Explained• Skool: Peptides Explained Community If you enjoy the show, please follow, subscribe, leave a review, and share this episode with someone who would benefit from understanding the science behind menopause, hormones, and peptide therapy. Peptides Explained is powered by Peptide Solutions, founded and operated by John Garrett, RN, providing education on peptide science and helping connect patients and clinicians with peptide-related resources. This podcast is for informational purposes only and is not medical advice.

    20 mnt
  2. 18 Mei

    BPC-157 and Cancer: What the Studies Actually Show

    Does BPC-157 cause cancer — or is that claim being oversimplified? In this episode of Peptides Explained, we take a study-review approach to one of the biggest concerns surrounding BPC-157: its potential angiogenic effects and whether that could theoretically contribute to cancer proliferation. Angiogenesis means new blood vessel formation. It is essential for normal wound healing and tissue repair, but it also plays a role in tumor biology. That overlap has led to concerns that BPC-157 could “feed” cancer growth. But what do the studies actually show? In this episode, we review key papers on BPC-157, including: • Hsieh et al., 2017 — VEGFR2 activation and angiogenesis• Radeljak, Seiwerth, and Sikiric, 2004 — melanoma cell-line data• Kang et al., 2018 — cancer cachexia context• Masnec et al., 2015 — corneal injury and neovascularization We break down the difference between physiologic repair signaling and pathologic tumor angiogenesis, and explain why the current evidence does not support the simple claim that BPC-157 causes cancer proliferation. That said, the lack of strong human oncology safety data means caution is still appropriate, especially for anyone with active cancer, prior cancer, unexplained symptoms, or elevated cancer risk. This episode is designed as a literature review for clinicians, physicians, and scientifically curious listeners who want a balanced, evidence-based explanation. Disclaimer: This content is for informational and educational purposes only and is not medical advice. Always consult a licensed healthcare professional before considering any therapy. Affiliate disclosure: Peptides Explained is an affiliate partner with OfflinePeptides.com. If you use my link, I may earn a commission at no additional cost to you.https://offlinepeptides.com/ref/JohnGarrett/ #BPC157 #PeptidesExplained #CancerRisk #Angiogenesis #PeptideScience #VEGF #TissueRepair #MedicalEducation #PhysicianReview #Peptides

    30 mnt

Mengenai

Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more. Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they’re popular, what the research shows, and the real risks and side effects — all in plain language. No bro science. No hype. Just clear, foundational education. For informational purposes only. Not medical advice. For Research Peptides; Offlinepeptides.com/ref/johngarrett/ https://www.skool.com/peptides-explained-15

Mungkin Anda Juga Suka